AletheiaHQ
DIR-D7-B9E-TT60/LVL 4·Multi-disciplinary TeamScoped operation requiring two or more distinct Vectors (disciplines). Cannot be executed solo. Examples: developer + lawyer targeting a new EU regulation compliance gap; logistics operator + finance operator arbitraging a carbon-tax supply disruption./75% confidence
Return to Directory

Build SBIR Biotech Commercialization Gap Database for Pharma BD Teams

Organization
NSF SBIR Phase I program's public award database (information asymmetry)
Sector
Pharma business development teams hunting for de-risked assets at fire-sale prices
Location
Location unspecified
// Venture Capital// Biotech// Database Management// Pharmacology// Data Scraping// IP// Open-Source Intelligence// Data Engineering & Pipelines

Executive Context

NSF awarded $305K SBIR Phase I grant to AICONIC BIOSCIENCES LLC for AI-assisted gene therapy platform targeting hearing disorders, creating an 18-month research validation period ending Dec 2027 with no automatic commercialization pathway. The structural discontinuity between academic validation and market deployment represents a $350M revenue opportunity trapped by institutional design constraints.

Catalyst / Timing

NSF publishes SBIR award data but doesn't track what happens post-grant. Pharma BD teams need real-time intelligence on which technologies validate, which teams fail to secure follow-on funding, and which therapeutic areas have highest abandonment rates - creating a $50K+/year data product opportunity.

Projected Yield

$250-375K ARR from subscriptions + $400-600K from matchmaking fees

Structural Friction

• Vulnerability: NSF publishes SBIR award data but doesn't track what happens post-grant. Pharma BD teams need real-time intelligence on which technologies validate, which teams fail to secure follow-on funding, and which therapeutic areas have highest abandonment rates - creating a $50K+/year data product opportunity. • Capital yield: $250-375K ARR from subscriptions + $400-600K from matchmaking fees • Resource capture: Proprietary database with predictive algorithms • Influence capture: Authority as broker between stranded SBIR assets and pharma acquirers • Sovereignty yield: Control of definitive SBIR biotech commercialization intelligence dataset • Required vectors: Vector: Data Engineering/Scraping, Vector: Business Intelligence/Analytics, Vector: Pharma Business Development, Vector: Software Development

Required Capabilities

  • Vector: Data Engineering/Scraping

    Primary executor: Phase 1: Data Acquisition & Enrichment Pipeline: Scrape NSF SBIR award database (API: https://www.nsf.gov/awardsearch/do

  • Vector: Business Intelligence/Analytics

    Supporting vector for: Build SBIR Biotech Commercialization Gap Database for Pharma BD Teams

  • Vector: Pharma Business Development

    Supporting vector for: Build SBIR Biotech Commercialization Gap Database for Pharma BD Teams

  • Vector: Software Development

    Supporting vector for: Build SBIR Biotech Commercialization Gap Database for Pharma BD Teams

Execution Protocol

Execution Protocol Locked

A one-time payment of $649 unlocks the exact wedge, required assets, and step-by-step execution parameters yours forever, no subscription.

This report is synthesized intelligence, not verified instruction. Always confirm against the primary source before acting. Review the full legal disclaimer before proceeding.